Interaction of POB1, a Downstream Molecule of Small G Protein
Ral, with PAG2, a Paxillin-binding Protein, Is Involved in Cell
Migration*
Takafumi
Oshiro
§,
Shinya
Koyama
,
Shinichiro
Sugiyama
,
Akiko
Kondo¶,
Yasuhito
Onodera¶,
Toshimasa
Asahara§,
Hisataka
Sabe¶, and
Akira
Kikuchi
From the Departments of
Biochemistry and
§ Surgery, Graduate School of Biomedical Sciences, Hiroshima
University, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8551, Japan and the
¶ Department of Molecular Biology, Osaka Bioscience Institute,
6-2-4 Furuedai, Suita, Osaka 565-0874, Japan
Received for publication, April 10, 2002, and in revised form, July 17, 2002
 |
ABSTRACT |
POB1 was previously identified as a
RalBP1-binding protein. POB1 and RalBP1 function downstream of small G
protein Ral and regulate receptor-mediated endocytosis. To look for
additional functions of POB1, we screened for POB1-binding proteins
using a yeast two-hybrid method and found that POB1 interacts with
mouse ASAP1, which is a human PAG2 homolog. PAG2 is a
paxillin-associated protein with ADP-ribosylation factor
GTPase-activating protein activity. POB1 formed a complex with PAG2 in
intact cells. The carboxyl-terminal region containing the proline-rich
motifs of POB1 directly bound to the carboxyl-terminal region including the SH3 domain of PAG2. Substitutions of Pro423 and
Pro426 with Ala (POB1(PA)) impaired the binding of POB1 to
PAG2. Expression of PAG2 inhibited fibronectin-dependent
migration and paxillin recruitment to focal contacts of CHO-IR cells.
Co-expression with POB1 but not with POB1(PA) suppressed the inhibitory
action of PAG2 on cell migration and paxillin localization. These
results suggest that POB1 interacts with PAG2 through its proline-rich motif, thereby regulating cell migration.
 |
INTRODUCTION |
We have identified an
EH1 domain-containing protein
that binds to RalBP1, which is an effector protein of small G protein
Ral (1), and named this protein POB1 (2). POB1 has a single EH domain
in its amino-terminal region and proline-rich motifs and a coiled-coil
structure in its carboxyl-terminal region. The EH domain has been
initially identified as a repeated sequence present in three copies in
the amino-terminal region of Eps15 and of the related molecule Eps15R,
two substrates of the EGF receptor kinase (3, 4). Reps1 (for
RalBP1-associated Eps-homology domain protein), intersectin, Pan1, and
End3 contain the EH domain in addition to Eps15, Eps15R, and POB1
(5). Eps15 binds to
-adaptin, a subunit of the clathrin
adaptor complex, AP-2 (6). The AP-2-binding site of Eps15 acts dominant
negatively in blocking the endocytosis of EGF, transferrin, or Sindbis
virus, indicating that Eps15 is actively required for the endocytic
process (7, 8). Eps15R has a 47% amino acid identity with and exhibits similar characteristics to Eps15 (4, 9). The POB1-related protein Reps1
has been identified as a RalBP1-binding protein (10). Intersectin (Ese)
has five SH3 domains in addition to two EH domains and is involved in
the regulation of internalization of the transferrin receptor (11, 12).
Pan1 and End3 are Saccharomyces cerevisiae dimeric partners
that are necessary for endocytosis of the
-mating factor receptor
and for normal organization of the actin cytoskeleton (13, 14). Thus,
the EH domain-containing proteins regulate endocytosis.
EGF and insulin stimulate the GDP/GTP exchange of Ral through Ras and
RalGDS (15-17), and the GTP-bound active form of Ral interacts with
RalBP1 (1). The carboxyl-terminal region of POB1 binds to RalBP1 (2).
Because the binding sites of Ral and POB1 on RalBP1 are different,
these three proteins form a ternary complex. EGF stimulates tyrosine
phosphorylation of POB1 and induces the complex formation between EGF
receptor and POB1 (2). The EH domain of POB1 associates with Eps15 and
Epsin (18, 19). Epsin also regulates endocytosis by directly binding to
phospholipids (20),
-adaptin (21), and clathrin (22, 23). Expression
of the EH domain or the carboxyl-terminal region of POB1 inhibits the
internalization of EGF and insulin (18). Therefore, it is conceivable
that Ral, RalBP1, and POB1 regulate receptor-mediated endocytosis by
transmitting the signal from receptors to Eps15 and Epsin.
The Arf family of small G proteins is divided into three classes based
largely on sequence similarity: class I (Arfs 1-3), class II (Arfs 4 and 5), and class III (Arf6) (24). By linking GTP binding and
hydrolysis, Arfs regulate membrane trafficking at various steps (25,
26). For instance, Arf6 has been implicated in the regulation of
membrane trafficking between the plasma membrane and a specialized
endocytic component. Moreover, its function has been linked to
cytoskeletal reorganization (27, 28). As with other small G proteins,
the activity of Arfs is regulated by guanine nucleotide exchange
factors and GAPs. It has been shown that ArfGAP is involved in
regulating the organization of focal adhesions (29, 30). Evidence for a
direct link between Arf signaling and focal adhesions came initially
from the identification of the ArfGAP protein as a paxillin-binding
protein. There are several ArfGAP families. All ArfGAP proteins share
homology within the zinc-finger-containing ArfGAP domain and ankyrin
repeat region. Among ArfGAP family proteins, PAG3 contains a pleckstrin
homology domain in an extended amino terminus and has a proline-rich
sequence followed by an SH3 domain at the carboxyl terminus (31). PAG3 binds to paxillin and serves as a GAP for Arf6. Overexpression of PAG3
in fibroblasts inhibits cell motility and reduces the paxillin
recruitment to focal contacts in a GAP-dependent manner (31). These results suggest that PAG3 plays a role in mediating changes
in cell motility.
To find additional functions of POB1, we screened proteins that bind to
POB1. Here we report that the proline-rich domain of POB1 interacts
with the SH3 domain of PAG2, a PAG3 homolog. Furthermore, we show that
the functional interaction of POB1 with PAG2 may regulate cell
migration. These results suggest that POB1 and PAG2 link the processes
of endocytosis and cell motility.
 |
EXPERIMENTAL PROCEDURES |
Materials and Chemicals--
Recombinant baculovirus expressing
GST-POB1 was provided by Dr. Y. Matsuura (Research Center for Emerging
Infectious Diseases, Research Institute for Microbial Diseases, Osaka
University). Hygromycin-resistant CHO-IR cells that stably express
POB1, PAG2, or their mutants were propagated as described (32). CHO-IR
cells stably expressing both POB1 and PAG2, both
POB1P423A/P426A and PAG2, or both POB1 and
PAG2-(1-703) were generated by selecting with Blasticidin. The rabbit
polyclonal anti-GST and anti-MBP antibodies were made by a standard
method. The rabbit polyclonal anti-POB1 and anti-PAG2 antibodies were
prepared by immunization with recombinant POB1-(322-521) and
GST-PAG2-(935-1002), respectively. The mouse monoclonal anti-HA
antibody 12CA5 was kindly provided by Dr. Q. Hu (Chiron Corp.,
Emeryville, CA). The rabbit polyclonal anti-PAG3 antibody was
prepared as described (31). The mouse monoclonal anti-Myc antibody was
prepared from 9E10 cells. GST and MBP fusion proteins were purified
from Escherichia coli according to the manufacturer's
instructions. GST-POB1 was purified from Spodoptera
frugiperda (Sf) 9 cells. Other materials were from commercial sources.
Plasmid Construction--
Standard recombinant DNA techniques
were used to construct the following plasmids. To construct
pGBKT7/POB1-(321-521), pUC19/POB1 was digested with EcoRI
and the 0.57-kb fragment was inserted in EcoRI-cut pGBKT7.
To construct pBj-Myc/ASAP1-(1050-1147), pACT2/ASAP1-(1050-1147) was
digested with SmaI and BglII, and the 0.3-kb
fragment was inserted into XbaI-cut, Klenow
fragment-blunted, and BamHI-cut pBj-Myc. To construct
pUC19/POB1P423A/P426A, the 0.51-kb fragment encoding
POB1-(321-494), in which Pro423 and Pro426
were mutated to Ala, was synthesized by PCR, digested with
BglII and SacI, and inserted into
BglII- and SacI-cut pUC19/POB1 (full-length). To construct pCGN/ POB1P423A/P426A,
pUC19/POB1P423A/P426A was digested with EcoRI,
blunted with Klenow fragment, and digested with PmaCI. The
resultant fragment was inserted into SmaI-cut pCGN/POB1
(full-length). To construct
pGEX-KG/POB1-(322-521)P423A/P426A,
pUC19/POB1P423A/P426A was digested with
BglII and EcoRI, and the 0.59-kb fragment was inserted with BamHI- and EcoRI-cut pGEX-KG. To
construct pEGFP-c2/POB1P423A/P426A,
pUC19/POB1P423A/P426A was digested with EcoRI
and the 1.56-kb fragment was inserted into EcoRI-cut
pEGFP-c2. To construct pGEX-KG/POB1-(322-421), pGEX-KG/POB1-(422-521), and pGEX-KG/POB1-(429-521), the 0.3-kb fragment encoding POB1-(322-421), the 0.3-kb fragment encoding POB1-(422-521), and the 0.3-kb fragment encoding POB1-(429-521), respectively, were synthesized by PCR. The synthesized fragments were digested with BamHI and EcoRI, and
inserted into BamHI- and EcoRI-cut pGEX-KG. To
construct pEGFP-c2/POB1, pUC19/POB1 was digested with EcoRI
and the 1.56-kb fragment was inserted into EcoRI-cut
pEGFP-c2. The construction of pEBG/PAG2 and pEGFP-c1/PAG2 will be
described elsewhere. To construct pGEX-KG/PAG2-(1002-1132), pEBG/PAG2
was digested with NotI, which was blunted with Klenow fragment and digested with NheI. The resultant 0.39-kb
fragment was inserted into NcoI-cut, blunted with Klenow
fragment, and XbaI-cut pGEX-KG. To construct
pMAL-c2/PAG2-(1002-1132), pGEX-KG/PAG2-(1002-1132) was digested with
BamHI and SalI, and the resultant 0.39-kb
fragment was inserted into BamHI- and SalI-cut
pMAL-c2. The entire PCR products were sequenced, and the structures of
all plasmids were confirmed by restriction analyses.
pGEX-2T/POB1-(1-125), pGEX-2T/POB1-(126-227), pGEX-2T/POB1-(228-406), pGEX-2T/POB1-(322-521),
pGEX-2T/RalBP1-(364-647), pMAL-c2/RalBP1-(364-647), pCGN/POB1,
pGEX-2T/paxillin
, and pBJ-Myc/RalBP1 were constructed as described
(2, 19, 33-36).
Two-hybrid Screening--
Yeast strain Y190 was used as a host
for the two-hybrid screening (CLONTECH Laboratories
Inc., Palo Alto, CA). Yeast cells were grown on rich medium (YAPD)
containing 2% glucose, 2% Bact-peptone, 1% Bact-yeast extract, and
0.002% adenine sulfate. Yeast transformations were performed by the
lithium acetate method. Transformants were selected on SD medium
containing 2% glucose, 0.67% yeast nitrogen base without amino acids,
and necessary supplements. Y190 strain carrying pGBKT7/POB1-(321-521),
in which POB1-(321-521) was expressed as a fusion protein with the
GAL4 DNA-binding domain, was transformed with a mouse brain cDNA
library constructed in pACT2, in which cDNA was expressed as a
fusion protein with the GAL4 activator domain. Approximately 1.6 × 106 transformants were screened for the growth on SD
plate medium lacking tryptophan, leucine, and histidine as evidenced by
transactivation of a GAL4-HIS3 reporter gene and histidine prototrophy.
His+ colonies were scored for
-galactosidase activity.
Plasmids harboring cDNAs were recovered from positive colonies and
introduced by electroporation into E. coli HB101 on M9
plates lacking leucine. HB101 is leuB
, and
this defect can be complemented by the LEU2 gene in the library plasmids. The library plasmids were then recovered from HB101
and transformed into Y190 containing pGBKT7/POB1-(321-521). The
nucleotide sequence of the plasmid cDNAs, which conferred the
LacZ+ phenotype on Y190 containing pGBKT7/POB1-(321-521),
was determined.
Complex Formation of POB1 with PAG2 in Intact Cells--
CHO-IR
cells or COS cells (6-cm diameter dishes) transfected with pCGN-,
pEBG-, and pBJ-Myc-derived plasmids were lysed in 200 µl of lysis
buffer (20 mM Tris/HCl, pH 7.5, 1% Nonidet P-40, 137 mM NaCl, 10% glycerol, 1 mM
phenylmethylsulfonyl fluoride, 20 µg/ml aprotinin, and 20 µg/ml
leupeptin) as described (18). The lysates (200 µg of protein) were
immunoprecipitated with the anti-Myc, anti-HA, or anti-POB1 antibody,
or precipitated with glutathione-Sepharose 4B. The precipitates were
washed once with 20 mM Tris/HCl, pH 7.5, 1% Nonidet P-40,
137 mM NaCl, and 10% glycerol, twice with 100 mM Tris/HCl, pH 7.5, and 0.5 M LiCl, and once
with 10 mM Tris/HCl, pH 7.5. The precipitates were probed with the anti-PAG2, anti-PAG3, anti-POB1, anti-HA, anti-Myc, and anti-GST antibodies. Where specified, the lysates of the cells expressing GST-PAG2, HA-POB1, and Myc-RalBP1 were used.
To examine whether paxillin interacts with the complex of PAG2 and
POB1, CHO-IR cells (10-cm diameter plate) expressing HA-POB1 and/or
GFP-PAG2 were lysed in 0.25 ml of lysis buffer. The lysates (480 µg
of protein) were incubated with 5 µg of GST-paxillin
immobilized
on glutathione-Sepharose 4B for 1 h at 4 °C. After glutathione-Sepharose 4B was precipitated by centrifugation, the precipitates were probed with the anti-GFP and anti-HA antibodies.
When the complex formation of POB1 with PAG3 was examined, 293 cells
(6-cm diameter dishes) were lysed in 200 µl of lysis buffer. The
lysates (180 µg of protein) were immunoprecipitated with the
anti-POB1 antibody, and the immunoprecipitates were probed with the
anti-PAG3 and anti-POB1 antibodies.
Direct Binding of POB1 and Paxillin to PAG2 in
Vitro--
Various GST-fused POB1 deletion mutants (0.5 µM each) were incubated with 20 pmol of
MBP-PAG2-(1002-1132) immobilized on amylose resin in 100 µl of
reaction mixture (20 mM Tris/HCl, pH 7.5, and 1 mM dithiothreitol) for 1 h at 4 °C. After the resin
was precipitated by centrifugation, the precipitates were probed with
the anti-GST antibody.
To show the simultaneous binding of PAG2 to POB1 and paxillin in
vitro, 0.5 µM GST-POB1-(322-521) and/or 1-4
µM GST-paxillin were incubated with 20 pmol of
MBP-PAG2-(1002-1132) or MBP immobilized on amylose resin in 100 µl
of reaction mixture (20 mM Tris/HCl, pH 7.5, and 1 mM dithiothreitol) for 1 h at 4 °C. After the resin was precipitated by centrifugation, the precipitates were probed with
the anti-GST antibody.
SPR Spectroscopy--
The binding of MBP-PAG2-(1002-1132) to
GST-POB1 was investigated by real-time SPR spectroscopy (BIACORE X,
BIAcore System, Uppsala, Sweden). Measurements were performed at
25 °C in HBS-EP buffer (10 mM HEPES/NaOH, pH 7.4, 150 mM NaCl, 3 mM EDTA, 0.005% polysorbate 20) at
a flow rate of 20 µl/min. GST-POB1 was coupled to a CM5 sensor tip in
amounts to yield 800 resonance units (RU) (1 RU is equal to 1 pg/mm2), via the goat anti-GST antibody that was
covalently coupled to the surface of the sensor tip by standard
amine-coupling chemistry. GST was coupled to the reference cell.
MBP-PAG2-(1002-1132) was injected for 180 s followed by elution
in HBS-EP buffer for 180 s. The observed changes in the relative
diffraction indices, which represents the mass on the sensor tip
surface, were recorded as a function of time. The value obtained from
the reference cell, which represented nonspecific binding of MBP fusion
proteins to GST, was subtracted from that with GST-POB1. Association
and dissociation constants of the PAG2-POB1 complex were calculated
using the BIAevaluation program version 3.1 (BIAcore).
Kd was calculated by fitting the data to the
equation Kd = kd/ka.
Cell Adhesion Assay--
The CHO-IR cells (5 × 104) were added to a 96-well dish that was precoated with
10 µg/ml fibronectin or BSA in PBS for 2 h. After 30 min of
incubation, the cells were washed with PBS three times. Adherent cells
were then fixed and stained with 0.1% crystal violet in 20% methanol
for 5 min at room temperature and were washed with PBS extensively. The
stain was eluted with 100 µl of 50% ethanol, and the absorbance at
590 nm was measured as described (37).
Cell Migration Assay--
The cell migration assay was performed
using a modified Boyden chamber (tissue culture treated, 6.5-mm
diameter, 10-µm thickness, 8-µm pore; Transwell, Costar, Cambridge,
MA) as described (38). In brief, only the underside surface of the
polycarbonate membrane on the upper chamber was coated with 10 µg/ml
fibronectin or BSA in PBS for 2 h. After the chamber was rinsed
with PBS, it was placed into the lower chamber filled with 400 µl of
Ham's F-12 medium containing 1% fetal calf serum. CHO-IR cells
(2.5 × 104) suspended in the Ham's F-12 medium
containing 0.1% BSA at 2.5 × 105 cells/ml were
applied to the upper chamber and allowed to migrate to the underside of
the upper chamber for 3 h at 37 °C with 5% CO2.
After the nonmigrated cells on the upper membrane surface were removed
with a cotton swab, cells that migrated to the underside of the upper
chamber were fixed with 4% paraformaldehyde in PBS and were stained
with propidium-iodide solution. The number of the stained cells was
counted and percent cell migration was calculated by dividing the
number of stained cells by the number of applied cells.
Immunofluorescence Study--
The CHO-IR cells expressing
GST-PAG2, GFP-POB1, or GFP-POB1(PA) were grown on coverslips and then
fixed for 20 min in PBS containing 4% paraformaldehyde. The cells were
washed with PBS three times and then permeabilized with PBS containing
0.1% Triton X-100 and 2 mg/ml BSA for 20 min. They were washed and
incubated for 1 h with the mouse monoclonal anti-paxillin and
rabbit polyclonal anti-GST antibodies. After being washed with PBS, the
cells were further incubated for 1 h with Cy5-labeled anti-mouse
IgG and Cy3-labeled anti-rabbit IgG. The coverslips were washed with
PBS and mounted on glass slides, and the fluorescence of Cy5, Cy3, and
GFP was viewed with a confocal laser-scanning microscope (LSM510, Carl-Zeiss, Jena, Germany). To determine the effects of POB1 on the
inhibitory action of PAG2 for the paxillin recruitment to focal
contacts, the number of cells where paxillin was recruited to focal
contacts was divided by the total number of the cells counted.
Approximately 100-300 cells were examined in each experiment.
 |
RESULTS |
Identification of PAG2 as a POB1-binding Protein--
Various
constructs used in this study are shown in Fig.
1. To discover new functions of POB1, we
attempted to identify POB1-binding protein(s). We screened a mouse
brain cDNA library by the yeast two-hybrid method using the
carboxyl-terminal region of POB1 (POB1-(322-521)) as bait. Several
clones were found to confer both His+ and LacZ+
phenotypes, and three of them overlapped, encoding the
carboxyl-terminal region of mouse ASAP1 (ASAP1-(1050-1147)). ASAP1 has
been identified as an ArfGAP and contains a zinc finger domain similar
to that required for GAP activity for Arf (39). ASAP1 also contains a
number of domains that are likely to be involved in regulation and/or
localization: a pleckstrin homology (PH) domain, three ankyrin (ANK)
repeats, a proline-rich region, and an SH3 domain. To examine whether
POB1 forms a complex with ASAP1 in intact cells, we expressed HA-POB1
and Myc-ASAP1-(1050-1147) in COS cells. When the lysates were
immunoprecipitated with the anti-Myc antibody, HA-POB1 was detected in
the Myc-ASAP1-(1050-1147) immune complexes under the conditions that
HA-POB1 formed a complex with Myc-RalBP1 (Fig.
2A). Previously we isolated
PAG2 and PAG3 as paxillin-binding proteins (31). Because human PAG2 has
a higher homology with mouse ASAP1 (95% identity) than human PAG3 does
(58% identity), we examined whether POB1 interacts with full-length
PAG2 in intact cells. GST-PAG2 was expressed in CHO-IR cells stably
expressing HA-POB1 (Fig. 2B, lanes 1 and
2). When the lysates of CHO-IR cells expressing both
GST-PAG2 and HA-POB1 were precipitated with glutathione-Sepharose, HA-POB1 was co-precipitated with GST-PAG2 (Fig. 2B,
lanes 3 and 4).

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 2.
Complex formation of POB1 with PAG2 in intact
cells. A, interaction of POB1 with ASAP1. Lysates of
COS cells expressing HA-POB1 alone (lane 2), HA-POB1 and
Myc-RalBP1 (lane 3), or HA-POB1 and Myc-ASAP1-(1050-1147)
(lane 4) were probed with the anti-HA and anti-Myc
antibodies. The same lysates were immunoprecipitated with the anti-Myc
antibody, and the immunoprecipitates were probed with the anti-Myc and
anti-HA antibodies (lanes 5-7). The lysates of COS cells
transfected with empty vectors were used as a control (lane
1). B, interaction of POB1 with PAG2. GST-PAG2 was
transiently expressed in CHO-IR cells stably expressing HA-POB1, and
the lysates were probed with the anti-GST and anti-HA antibodies
(lanes 1 and 2). The same lysates were
precipitated with glutathione-Sepharose, and the precipitates were
probed with the anti-GST and anti-HA antibodies (lanes 3 and
4). C, complex formation of POB1 with PAG2 or
PAG3 at endogenous level. The lysates of CHO-IR cells (lanes
1-3) or 293 cells (lanes 4-6) were probed with the
anti-PAG2 and anti-POB1 antibodies (lane 1) or the anti-PAG3
and anti-POB1 antibodies (lane 4). The same lysates were
immunoprecipitated with pre-immune serum (lanes 2 and
5) or the anti-POB1 antibody (lanes 3 and
6), and the immunoprecipitates were probed with the
anti-PAG2 and anti-POB1 antibodies (lanes 2 and
3) or the anti-PAG3 and anti-POB1 antibodies (lanes
5 and 6). Ig, immunoglobulin; Ab,
antibody; IP, immunoprecipitation. The results shown are
representative of three independent experiments.
|
|
Next, we asked whether endogenous PAG2 associated with endogenous POB1
in CHO-IR cells. When the lysates of CHO-IR cells were immunoprecipitated with the anti-POB1 antibody, PAG2 was detected in
the POB1 immune complex (Fig. 2C, lanes 1-3). We
also examined whether endogenous PAG3 interacted with endogenous POB1
in intact cells. Because PAG3 was expressed only slightly in CHO-IR
cells, we used 293 cells. Endogenous PAG3 was observed in the POB1
immune complex from 293 cells (Fig. 2C, lanes
4-6). These results indicate that POB1 forms a complex with PAG2
and PAG3 in intact cells at endogenous levels.
Direct Interaction of POB1 with PAG2--
To examine whether POB1
directly interacts with PAG2, GST-POB1 (full-length) was purified from
Sf9 cells. Because it was difficult to purify full-length PAG2,
PAG2-(1002-1132), which corresponds to ASAP1-(1050-1147), was
purified as an MBP fusion protein. GST-POB1 was precipitated with
MBP-PAG2-(1002-1132) but not with MBP (Fig. 3A). These results indicate
that POB1 binds to PAG2 directly.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 3.
Direct binding of POB1 to PAG2 in
vitro. A, binding of POB1 to PAG2.
GST-POB1 and MBP-PAG2-(1002-1132) (0.5 µg of protein) were stained
with Coomassie Brilliant Blue (lanes 1 and 2).
After 0.4 µM GST-POB1 was incubated with 0.5 µM MBP-PAG2-(1002-1132) or MBP immobilized on amylose
resin, the mixtures were centrifuged. The precipitates were probed with
the anti-GST and anti-MBP antibodies (lanes 3 and
4). The results shown are representative of three
independent experiments. B, SPR spectrometry. The indicated
concentrations of MBP-PAG2-(1002-1132) or MBP were injected onto a
chip surface with immobilized GST-POB1. Binding was allowed to occur
for 180 s, followed by dissociation in the running buffer for
180 s. The results shown are representative of three independent
experiments.
|
|
To determine the association and dissociation rates of complex
formation between POB1 and PAG2, we performed real time SPR analysis
(Fig. 3B). For this purpose, GST-POB1 and GST were
immobilized onto a CM5 sensor tip surface via the anti-GST antibody,
which was covalently coupled to the surface by standard amine-coupling chemistry. GST was immobilized onto the surface of the reference cell
on the same sensor tip. Four different concentrations (17, 33, 67, and
133 nM) of MBP-PAG2-(1002-1132) or 100 nM MBP
were injected onto the surface of the sensor tip at 25 °C for
180 s to form the complex, and then the sensor tip was washed with
the buffer for 180 s to dissociate the complex. The association
rate ka for the binding of MBP-PAG2-(1002-1132)
was determined to be 1.06 ± 0.02 × 105
M
1 s
1 and the dissociation rate
kd to be 1.44 ± 0.02 × 10
3 s
1. The static dissociation constant
Kd was calculated as 13.6 nM. Thus, POB1
binds to PAG2 with high affinity, consistent with the observations that
these proteins form a complex at endogenous levels.
Identification of the Sites of POB1 that Bind to PAG2--
To
determine which region of POB1 is necessary for its binding to PAG2,
various deletion mutants of POB1 were purified as GST fusion proteins
(Fig. 4A, lanes
1-7). As PAG2-(1002-1132) contains the SH3 domain, we speculated
that the proline-rich motifs of POB1 are important for the binding. As
expected, GST-POB1-(1-125), GST-POB1-(126-227), and
GST-POB1-(429-521), which do not contain the proline-rich motifs, did
not bind to MBP-PAG2-(1002-1132) (Fig. 4A, lanes
8, 9, and 13). POB1 contains three
proline-rich motifs, PPTPPPRP345,
PPPPALPPRP383, and PPSKPIR428.
GST-POB1-(228-406) and GST-POB1-(322-421), which contain only the
first and second proline-rich motifs, did not associate with MBP-PAG2-(1002-1132) (Fig. 4A, lanes 10 and
11). GST-POB1-(322-521) and GST-POB1-(422-521), which
include the third proline-rich motif, interacted with
MBP-PAG2-(1002-1132) (Fig. 4A, lanes 12 and
14). These results suggest that the third proline-rich motif
of POB1 is important for the binding to PAG2. To confirm this
possibility, both Pro423 and Pro426 of POB1
were substituted with Ala (POB1(PA)). When GST-POB1-(322-521) and
GST-POB1-(322-521)(PA) were incubated with MBP-PAG2-(1002-1132), GST-POB1-(322-521) but not GST-POB1-(322-521)(PA) bound to
MBP-PAG2-(1002-1132) (Fig. 4B, lanes 7 and
8). Under the same conditions, both GST-POB1-(322-521) and
GST-POB1-(322-521)(PA) interacted with MBP-RalBP1-(364-647), which is
known to contain the POB1-binding region (Fig. 4B,
lanes 5 and 6). These observations were also
confirmed in intact cells. Although Myc-RalBP1 formed a complex with
HA-POB1(PA) in CHO-IR cells, GST-PAG2 did not (Fig. 4C).
These results clearly indicate that Pro423 and
Pro426 of POB1 are essential for the interaction with PAG2
and that the sites on POB1 that bind to PAG2 and RalBP1 are
different.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 4.
Sites of POB1 that bind to PAG2.
A, binding of deletion mutants of POB1 to PAG2.
GST-POB1-(1-125) (lane 1), GST-POB1-(126-227) (lane
2), GST-POB1-(228-406) (lane 3), GST-POB1-(322-421)
(lane 4), GST-POB1-(422-521) (lane 5),
GST-POB1-(429-521) (lane 6), and GST-POB1-(322-521)
(lane 7) (1 µg of protein) were stained with Coomassie
Brilliant Blue. After 0.5 µM GST-POB1 deletion mutants
had been incubated with 0.2 µM MBP-PAG2-(1002-1132)
immobilized on amylose resin, the mixtures were centrifuged. The
precipitates were probed with the anti-GST (upper panel) and
anti-MBP (lower panel) antibodies (lanes 8-14).
The amounts of precipitated MBP-PAG2-(1002-1132) are shown in the
lower panel. B, inability of POB1(PA) to bind to PAG2
in vitro. MBP-RalBP1- (364-647) (lane 1),
MBP-PAG2-(1002-1132) (lane 2), GST-POB1-(322-521)
(lane 3), and GST-POB1-(322-521)(PA) (lane 4)
(0.5 µg of protein) were subjected to SDS-PAGE followed by Coomassie
Brilliant Blue staining. After 0.5 µM GST-POB1-(322-521)
or GST-POB1-(322-521)(PA) had been incubated with 0.2 µM
MBP-RalBP1-(364-647) (lanes 5 and 6) or 0.2 µM MBP-PAG2-(1002-1132) (lanes 7 and
8), the mixtures were precipitated with amylose resin. The
precipitates were probed with the anti-GST and anti-MBP antibodies.
WT, GST-POB1-(322-521); PA,
GST-POB1-(322-521)(PA). C, inability of POB1(PA) to complex
with PAG2 in intact cells. The lysates of CHO-IR cells expressing
HA-POB1 and Myc-RalBP1 (lane 1), HA-POB1(PA) and Myc-RalBP1
(lane 2), HA-POB1 and GST-PAG2 (lane 3), or
HA-POB1(PA) and GST-PAG2 (lane 4) were probed with the
anti-GST, anti-Myc, and anti-HA antibodies. The same lysates of CHO-IR
cells were immunoprecipitated with the anti-HA antibody (lanes
5-8). The immunoprecipitates were probed with the anti-GST,
anti-Myc, and anti-HA antibodies. WT, wild-type HA-POB1;
PA, HA-POB1(PA). The results shown are representative of
three independent experiments.
|
|
Complex Formation of POB1, PAG2, and RalBP1--
Based on the
results in Fig. 4, we examined whether POB1, PAG2, and RalBP1 form a
complex using purified proteins in vitro. When
GST-POB1-(322-521) and GST-RalBP1-(364-647) were incubated with
MBP-PAG2-(1002-1132) immobilized on amylose resin,
GST-RalBP1-(364-647) formed a complex with MBP-PAG2-(1002-1132) in a
manner dependent on the dose of GST-POB1-(322-521) (Fig.
5A, lanes 2-4). On
the other hand, RalBP1 did not bind to PAG2 directly in the absence of
POB1 (Fig. 5A, lane 1). When GST was used instead
of GST-POB1-(322-521), GST-RalBP1-(364-647) could not form a complex
with MBP-PAG2-(1002-1132) (data not shown). When various amounts of
GST-RalBP1-(364-647) and a fixed amount of GST-POB1-(322-521) were
incubated with MBP-PAG2-(1002-1132) immobilized on amylose resin,
GST-RalBP1-(364-647) formed a complex with MBP-PAG2-(1002-1132) in a
dose-dependent manner (Fig. 5A, lanes
5-8). These observations were also confirmed in intact cells (Fig. 5B). When the lysates of CHO-IR cells expressing
Myc-RalBP1 and GST-PAG2 were immunoprecipitated with the anti-Myc
antibody, GST-PAG2 was faintly detected in the Myc-RalBP1 immune
complex, suggesting that RalBP1 forms a complex with PAG2 via
endogenous POB1 (Fig. 5B, lanes 2 and
6). Additional expression of HA-POB1 enhanced the complex
formation of GST-PAG2 and Myc-RalBP1 (Fig. 5B, lanes
3 and 7). However, HA-POB1(PA) did not allow Myc-RalBP1 to associate with GST-PAG2, and instead inhibited formation of the
complex (Fig. 5B, lanes 4 and 8).
These results suggest that RalBP1, POB1, and PAG2 may form a ternary
complex.

View larger version (87K):
[in this window]
[in a new window]
|
Fig. 5.
Complex formation of POB1, PAG2, and
RalBP1. A, binding of RalBP1 to PAG2 through POB1
in vitro. 1 µM GST-RalBP1-(364-647) was
incubated with 0.5 µM MBP-PAG2-(1002-1132) immobilized
on amylose resin in the presence of the indicated concentrations of
GST-POB1-(322-521) (lanes 1-4). 1 µM
GST-POB1-(322-521) was incubated with 0.5 µM
MBP-PAG2-(1002-1132) immobilized on amylose resin in the presence
of the indicated concentrations of GST-RalBP1-(364-647) (lanes
5-8). MBP-PAG2-(1002-1132) was precipitated and the precipitates
were probed with the anti-GST and anti-MBP antibodies. B,
binding of RalBP1 to PAG2 through POB1 in intact cells. The lysates of
CHO-IR cells expressing GST-PAG2 alone (lane 1), Myc-RalBP1
and GST-PAG2 (lane 2), Myc-RalBP1, GST-PAG2, and HA-POB1
(lane 3), or Myc-RalBP1, GST-PAG2, and HA-POB1(PA)
(lane 4) were probed with the anti-GST, anti-Myc, and
anti-HA antibodies. The same lysates were immunoprecipitated with the
anti-Myc antibody (lanes 5-8) and probed with the anti-GST,
anti-Myc, and anti-HA antibodies. WT, wild-type HA-POB1;
PA, HA-POB1(PA). The results shown are representative of
three independent experiments.
|
|
Complex Formation of POB1, PAG2, and Paxillin--
Because PAG2 is
a homolog of PAG3, we examined whether PAG2 also binds to paxillin.
When the lysates of CHO-IR cells expressing either GFP-PAG2 or HA-POB1
were incubated with GST-paxillin, GFP-PAG2 associated with
GST-paxillin, but HA-POB1 interacted with GST-paxillin only faintly
(Fig. 6A, lanes
7-10). When the lysates of CHO-IR cells expressing both GFP-PAG2
and HA-POB1 were incubated with GST-paxillin, both proteins formed a
complex with GST-paxillin but not with GST (Fig. 6A,
lanes 11 and 12). HA-POB1 formed a complex with
GST-paxillin more efficiently than when HA-POB1 was expressed alone
(Fig. 6A, lanes 10 and 12). These
results suggest that POB1 forms a complex with paxillin through PAG2
and that the complex of POB1 and PAG2 can bind to paxillin.

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 6.
Complex formation of POB1, PAG2, and
paxillin. A, binding of paxillin to POB1 through PAG2.
GST and GST-paxillin (0.5 µg of protein) were stained with
Coomassie Brilliant Blue (lanes 1 and 2). The
lysates of CHO-IR cells expressing GFP-PAG2 alone (lane 4),
HA-POB1 alone (lane 5), or GFP-PAG2 and HA-POB1 (lane
6) were probed with the anti-GFP and anti-HA antibodies. The
lysates of untransfected CHO-IR cells were used as a control
(lane 3). The same lysates were precipitated with 5 µg of
GST (lanes 7, 9, and 11) or
GST-paxillin (lanes 8, 10, and
12). The precipitates were probed with the anti-GFP and
anti-HA antibodies. An arrowhead indicates nonspecific
staining by the anti-HA antibody. B, simultaneous binding of
PAG2 to POB1 and paxillin in vitro. 0.5 µM
GST-POB1-(322-521) was incubated with 0.2 µM
MBP-PAG2-(1002-1132) immobilized on amylose resin in the presence of
the indicated concentrations of GST-paxillin (lanes
2-5). Incubation of MBP-PAG2-(1002-1132) alone was used as a
control (lane 1). To show the nonspecific binding, 0.5 µM GST-POB1-(322-521) or 4 µM GST-paxillin
was incubated with 0.2 µM MBP immobilized on amylose
resin (lanes 6 and 7). MBP-PAG2-(1002-1132) or
MBP was precipitated, and the precipitates were probed with the
anti-GST antibody. The results shown are representative of three
independent experiments.
|
|
Because we previously showed that PAG3-(863-1006) interacted with
paxillin (31), we examined whether PAG2-(1002-1132), which shares a
high homology with PAG3-(863-1006), binds to paxillin using purified
proteins in vitro. GST-POB1-(322-521) and GST-paxillin bound to MBP-PAG2-(1002-1132) but to MBP only faintly (Fig.
6B). Furthermore, GST-paxillin did not affect the complex
formation of GST-POB1-(322-521) with MBP-PAG2-(1002-1132) (Fig.
6B). Although we did not identify the binding site of
paxillin on PAG2, these results suggest that PAG2 can bind
simultaneously to both paxillin and POB1 and that these three proteins
may form a ternary complex.
Effects of POB1 on Cell Adhesion and Migration--
Cell adhesion
and migratory activities are primarily mediated by integrin adhesion to
the extracellular matrix. As it was shown that
overexpression of PAG3, a homolog of PAG2, decreases cell
migratory activity (31), we examined whether POB1 and PAG2 affect these
activities of CHO-IR cells. To this end, we generated CHO-IR cells
stably expressing POB1 mutants and/or PAG2 mutants (Fig.
7A). The cell adhesiveness
toward fibronectin of CHO-IR cells stably expressing HA-POB1
(CHO-IR/POB1) was similar to that of CHO-IR cells (Fig. 7B).
Furthermore, expression of HA-POB1(PA), GST-PAG2, GST-PAG2N, GST-PAG2C,
HA-POB1 and GST-PAG2, HA-POB1(PA) and GST-PAG2, or HA-POB1 and
GST-PAG2N did not affect cell adhesiveness (Fig. 7B).
Therefore, it is likely that POB1 and PAG2 are not involved in cell
adhesion. Overexpression of POB1 or POB1(PA) in CHO-IR cells did not
affect the cell migratory activity on fibronectin (Fig. 7C).
PAG2 caused a several-fold decrease in the cell migratory activity
(Fig. 7C). It has been shown that the ArfGAP activity of
PAG3 is essential for its ability to suppress cell migration (31). The
amino-terminal region of PAG2 contains the ArfGAP domain
(PAG2N-(1-703)). CHO-IR/PAG2N-(1-703) decreased cell migration
activity, whereas CHO-IR/PAG2C- (704-1132) showed similar activity
to CHO-IR cells. These results suggest that the ArfGAP domain, but not
the POB1-binding domain, of PAG2 is important for the ability to
suppress cell migration. Co-expression with POB1 but not with POB1(PA)
suppressed the PAG2-induced inhibition of motility (Fig.
7C). Moreover, co-expression with POB1 could not suppress
the inhibition of motility induced by PAG2N-(1-703) (Fig.
7C). These results suggest that the interaction of POB1 with
PAG2 prevents PAG2 from inhibiting cell migration.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 7.
Effects of POB1 on cell adhesion and
migration. A, CHO-IR cells expressing POB1 mutants
and/or PAG2 mutants. Lysates of wild-type CHO-IR cells or CHO-IR cells
stably expressing HA-POB1, HA-POB1(PA), GST-PAG2, GST-PAG2N, GST-PAG2C,
HA-POB1 and GST-PAG2, HA-POB1(PA) and GST-PAG2, or HA-POB1 and
GST-PAG2N were probed with the anti-HA and anti-GST antibodies.
PAG2N, GST-PAG2-(1-703); PAG2C,
GST-PAG2-(704-1132); POB1/PAG2, HA-POB1 and
GST-PAG2; POB1(PA)/PAG2, HA-POB1(PA) and
GST-PAG2; POB1/PAG2N, HA-POB1 and
GST-PAG2-(1-703). B, cell adhesion. The indicated CHO-IR
cells were subjected to the cell adhesion assay. White bars,
BSA-precoated; black bars, fibronectin-precoated. The
results shown are representative of three independent experiments.
C, cell migration. The indicated CHO-IR cells were subjected
to the cell migration assay. The results shown are means ± S.D.
of three independent experiments.
|
|
Effects of POB1 on the Inhibitory Action of PAG2 on the Paxillin
Recruitment to Focal Contacts--
Paxillin was condensed at focal
adhesion plaques at the bottom of the cells (Fig.
8A). Overexpression of PAG3
caused loss of endogenous paxillin recruitment to focal contacts (31).
As in the case of PAG3, when GST-PAG2 was overexpressed in CHO-IR cells, the staining of paxillin decreased (Fig. 8A,
a). When GST-PAG2 was co-expressed with GFP-POB1, paxillin
was observed as punctate structures, showing similar staining as in the
surrounding normal cells (Fig. 8A, d).
GFP-POB1(PA) did not influence the effect of GST-PAG2 on paxillin
staining (Fig. 8A, g). These results suggest that
POB1 suppresses the inhibitory action of PAG2 on the paxillin recruitment to focal contacts by binding to PAG2. To quantitatively determine the effects of POB1 on the inhibitory action of PAG2 on the
paxillin recruitment, the number of cells that showed clear staining of
paxillin at the cell bottom in the same slice was counted (Fig.
8B). In the normal cells surrounding the cells expressing GST-PAG2 and/or GFP-POB1, paxillin was observed in 68 ± 5.6% of all the cells examined. The percentages of the cells with clear staining of paxillin at the cell bottom in the cells expressing GST-PAG2 alone, GST-PAG2 and GFP-POB1, and GST-PAG2 and GFP-POB1(PA) were 24 ± 1.6%, 68 ± 11.1%, and 39 ± 9.8%,
respectively.

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 8.
Effects of POB1 on the inhibitory action of
PAG2 on the paxillin recruitment to focal contacts. A,
effects of POB1 and PAG2 on paxillin staining. CHO-IR cells transiently
expressing GST-PAG2 alone (a, b, and c), GST-PAG2
and GFP-POB1 (d, e, and f), or GST-PAG2 and
GFP-POB1(PA) (g, h, and i) were stained with the
anti-paxillin (a, d, and g) and anti-GST
(b, e, and h) antibodies and directly viewed for
GFP-POB1 (c, f, and i). Bar, 10 µm.
B, percentage of cells in which paxillin is recruited to
focal contacts. The number of cells in which paxillin was recruited to
focal contacts was divided by the total number of cells counted. The
results are shown as means ± S.D. of three independent
experiments.
|
|
 |
DISCUSSION |
In this study, we demonstrated the interaction of POB1 with PAG2.
Endogenous PAG2 was detected in the endogenous POB1 immune complex from
CHO-IR cells. Sf9-cell-produced GST-POB1 bound to bacterial
cell-produced MBP-PAG2-(1002-1132) containing the SH3 domain with a
Kd value of 13.6 nM. Therefore, it is
conceivable that POB1 binds directly to PAG2 under physiological
conditions. Furthermore, we demonstrated that the proline-rich motif of
POB1 is essential for the binding of POB1 to PAG2. POB1 has three
proline-rich motifs, PPTPPPRP345,
PPPPALPPRP383, and PPSKPIR428. It is generally
thought that the proline-rich motifs bind to several proteins such as
profilin and to the EVH1, SH3, and WW domains (40). The core motif that
binds to the SH3 domain is PXXP, and this motif is
further classified into class I and class II. The class I motif is
(R/K)XXPXXP, which binds to the SH3 domains of
Src, Abl, Fyn, and Lyn. The class II motif is
PXXPX(R/K), which binds to the SH3 domains of
Grb2, Nck, and Crk. All of the proline-rich motifs of POB1 are class II
of the SH3-domain binding motifs. Because substitution of two proline
residues with alanine in the third motif of POB1 impaired its binding
to PAG2, the third proline motif is essential for the binding to PAG2.
These results suggest that the proline-rich motifs of POB1 interact
with the SH3 domain of PAG2. It has been shown that the SH3 domain of
PAG3/PAP
binds to Pyk2 and that activation of Pyk2 leads to tyrosine
phosphorylation of PAP
(31, 41). Because the SH3 domain of PAG2
shares 76% identity with that of PAG3, PAG2 may interact with Pyk2. It
remains to be clarified whether POB1 affects the interaction of PAG2
with Pyk2. Previously we showed that among the SH3-domain-containing proteins, Grb2 but not Nck and Crk binds to POB1 (2). Because Grb2
bound to both POB1 and POB1(PA) (data not shown), it seems that the
third proline-rich motif of POB1 is not essential for its binding to
Grb2, suggesting that PAG2 and Grb2 bind to different sites of POB1.
Several lines of evidence indicate that ArfGAP family members,
including GIT, PAG3/PAP
, and ASAP1/DEF-1, regulate actin
cytoskeletal dynamics (30). PAG3 interacts with paxillin, which acts as
an adaptor molecule in integrin signaling and is localized to focal contacts (29, 31). PAG3 is diffusely distributed in the cytoplasm in
premature monocytes but becomes localized at cell periphery in mature
monocytes (31). However, PAG3 does not accumulate at focal contacts,
suggesting that PAG3 is not an integrin assembly protein.
Overexpression of PAG3 in COS-7 and U937 cells causes a loss of the
paxillin recruitment to focal adhesions and inhibits cell motility in a
GAP-dependent manner. Overexpression of PAG2 also impaired
cell migratory activities and inhibited paxillin recruitment to focal
contacts. This does not always reflect that PAG2 negatively regulates
cell migration because overexpression of PAG2 may interfere with the
functions of proteins that are involved in the cell migration through
recruitment of the binding partners even though PAG2 is a positive regulator.
The amino-terminal region of PAG2 containing the ArfGAP domain, but not
the carboxyl-terminal region containing the binding sites of paxillin
and POB1, inhibited cell migration. Taken together with the
observations that the activities of Arfs are involved in the focal
adhesion recruitment of paxillin (31, 42), it is conceivable that the
ArfGAP activity is essential for these activities of PAG2, but we do
not know the physiological roles of the paxillin-binding activity of
PAG2 for them. We also showed that POB1, but not POB1(PA), restores
cell motility and the paxillin recruitment to focal contacts, which are
inhibited by PAG2. Moreover, POB1 could not rescue the inhibition by
the amino-terminal region of PAG2 that lacks the POB1-binding site.
Therefore, the interaction of POB1 with PAG2 may regulate the paxillin
recruitment to focal contacts, but we do not know the mechanism at
present. One possibility might be that POB1 participates in the
recruitment of PAG2 to proper subcellular areas in which PAG2 may act
as a GAP for Arfs, resulting in the regulation of the subcellular
positioning of paxillin. It has been proposed that primer proteins
including the coatmer and the GTP-bound form of Arf at the membranes of the endoplasmic reticulum and the Golgi apparatus influence the catalytic activity of ArfGAP1 (43, 44). Therefore, complex formation
between paxillin, PAG2, and POB1 at certain subcellular areas may
constitute a signal necessary for the onset or the enhancement of the
catalytic GAP activity of PAG2 toward the GTP-bound form of Arfs.
Cell locomotion is driven by protrusive activity at the leading edge of
the cell where continuous remodeling of actin cytoskelton and adhesive
contacts is required (45). Endocytosed membrane is reinserted at the
leading edge of migrating cells, extending the front of the cell
forward. For instance, recycling transferrin receptors and low density
lipoprotein receptors are distributed to the cell front of migrating
fibroblasts and Rac-induced ruffles (46, 47). Therefore, it is likely
that the random reinsertion of internalized membranes at the surface of
a resting cell is redirected to the site of protrusion when migration
is induced by mitogenic stimuli. Arf6 is implicated in the regulation
of membrane trafficking between the recycling endosomal compartment and
the plasma membrane, based on the specific localization of Arf6 in
these compartments and the effects of its overexpression on transferrin
uptake and recycling to the cell surface (48, 49). Arf6 co-localizes
with Rac1, which is involved in the formation of actin-rich ruffles and
lamellipodia, at the plasma membrane and on recycling endosomes (50).
Moreover, the ArfGAP family proteins interact with proteins involved in
both cell adhesion and actin organization (30). Therefore, it has been
speculated that ArfGAP is involved in the regulation of Arf-mediated
membrane recycling and protrusion during cell locomotion.
We have demonstrated that small G protein Ral and its downstream
molecules, RalBP1 and POB1, are involved in receptor-mediated endocytosis of EGF and insulin (18). Furthermore, we have found that
Eps15 and Epsin bind directly to the EH domain of POB1 (18, 19). These
results suggest that the signaling from Ral to Eps15 and Epsin through
RalBP1 and POB1 regulates receptor-mediated endocytosis. Because Eps15
and Epsin are core proteins that regulate endocytosis, POB1 may be able
to link endocytosis and cell migration. The binding sites of POB1 for
Epsin, RalBP1, and PAG2 are different. Taken together with the
observations that Ral regulates both actin cytoskeletal remodeling and
vesicle transport (18, 37, 51, 52), it is intriguing to speculate that
POB1 may function as a scaffold protein in that it interacts with
proteins involved in endocytosis and migration to create a
multi-protein complex. Further analysis would be necessary to
understand how these complex interactions are temporally and spacially
coordinated during cell migration.
 |
ACKNOWLEDGEMENTS |
We thank Drs. Y. Matsuura and Q. Hu for
donating reagents.
 |
FOOTNOTES |
*
This work was supported in part by grants-in-aid for
Scientific Research (B) and for Scientific Research on priority areas (C) from the Ministry of Education, Science, and Culture, Japan (2000, 2001) and by grants from the Yamanouchi Foundation for Research
on Metabolic Disorders (2001).
To whom correspondence should be addressed: Dept. of
Biochemistry, Graduate School of Biomedical Sciences, Hiroshima
University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. Tel.:
81-82-257-5130; Fax: 81-82-257-5134; E-mail:
akikuchi@hiroshima-u.ac.jp.
Published, JBC Papers in Press, July 30, 2002, DOI 10.1074/jbc.M203453200
 |
ABBREVIATIONS |
The abbreviations used are:
EH, Eps15 homology;
G protein, GTP-binding protein;
EGF, epidermal growth factor;
SH3, Src
homology 3;
Arf, ADP-ribosylation factor;
GAP, GTPase-activating
protein;
GST, glutathione S-transferase;
CHO-IR, Chinese
hamster ovary-insulin receptor;
MBP, maltose-binding protein;
HA, hemagglutinin;
SPR, surface plasmon resonance;
BSA, bovine serum
albumin;
PBS, phosphate buffered saline;
GFP, green fluorescent
protein.
 |
REFERENCES |
| 1.
|
Feig, L. A.,
Urano, T.,
and Cantor, S.
(1996)
Trends Biochem. Sci.
21,
438-441[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Ikeda, M.,
Ishida, O.,
Hinoi, T.,
Kishida, S.,
and Kikuchi, A.
(1998)
J. Biol. Chem.
273,
814-821[Abstract/Free Full Text]
|
| 3.
|
Fazioli, F.,
Minichiello, L.,
Matoskova, B.,
Wong, W. T.,
and Di Fiore, P. P.
(1993)
Mol. Cell. Biol.
13,
5814-5828[Abstract/Free Full Text]
|
| 4.
|
Coda, L.,
Salcini, A. E.,
Confalonieri, S.,
Pelicci, G.,
Sorkina, T.,
Sorkin, A.,
Pelicci, P. G.,
and Di Fiore, P. P.
(1998)
J. Biol. Chem.
273,
3003-3012[Abstract/Free Full Text]
|
| 5.
|
Santolini, E.,
Salcini, A. E.,
Kay, B. K.,
Yamabhai, M.,
and Di Fiore, P. P.
(1999)
Exp. Cell Res.
253,
186-209[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Iannolo, G.,
Salcini, A. E.,
Gaidarov, I.,
Goodman, O. B. J.,
Baulida, J.,
Carpenter, G.,
Pelicci, P. G., Di,
Fiore, P. P.,
and Keen, J. H.
(1997)
Cancer Res.
57,
240-245[Abstract/Free Full Text]
|
| 7.
|
Carbone, R.,
Fre, S.,
Iannolo, G.,
Belleudi, F.,
Mancini, P.,
Pelicci, P. G.,
Torrisi, M. R.,
and Di Fiore, P. P.
(1997)
Cancer Res.
57,
5498-5504[Abstract/Free Full Text]
|
| 8.
|
Benmerah, A.,
Lamaze, C.,
Begue, B.,
Schmid, S. L.,
Dautry-Varsat, A.,
and Cerf-Bensussan, N.
(1998)
J. Cell Biol.
140,
1055-1062[Abstract/Free Full Text]
|
| 9.
|
Wong, W. T.,
Schumacher, C.,
Salcini, A. E.,
Romano, A.,
Castagnino, P.,
Pelicci, P. G.,
and Di Fiore, P. P.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
9530-9534[Abstract/Free Full Text]
|
| 10.
|
Yamaguchi, A.,
Urano, T.,
Goi, T.,
and Feig, L. A.
(1997)
J. Biol. Chem.
272,
31230-31234[Abstract/Free Full Text]
|
| 11.
|
Yamabhai, M.,
Hoffman, N. G.,
Hardison, N. L.,
McPherson, P. S.,
Castagnoli, L.,
Cesareni, G.,
and Kay, B. K.
(1998)
J. Biol. Chem.
273,
31401-31407[Abstract/Free Full Text]
|
| 12.
|
Sengar, A. S.,
Wang, W.,
Bishay, J.,
Cohen, S.,
and Egan, S. E.
(1999)
EMBO J.
18,
1159-1171[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Benedetti, H.,
Raths, S.,
Crausaz, F.,
and Riezman, H.
(1994)
Mol. Biol. Cell
5,
1023-1037[Abstract]
|
| 14.
|
Tang, H. Y.,
Munn, A.,
and Cai, M.
(1997)
Mol. Cell. Biol.
17,
4294-4304[Abstract]
|
| 15.
|
Kikuchi, A.,
Demo, S. D., Ye, Z.-H.,
Chen, Y.-W.,
and Williams, L. T.
(1994)
Mol. Cell. Biol.
14,
7483-7491[Abstract/Free Full Text]
|
| 16.
|
Kishida, S.,
Koyama, S.,
Matsubara, K.,
Kishida, M.,
Matsuura, Y.,
and Kikuchi, A.
(1997)
Oncogene
15,
2899-2907[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Wolthuis, R. M. F.,
Zwartkruis, F.,
Moen, T. C.,
and Bos, J. L.
(1998)
Curr. Biol.
8,
471-474[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Nakashima, S.,
Morinaka, K.,
Koyama, S.,
Ikeda, M.,
Kishida, M.,
Okawa, K.,
Iwamatsu, A.,
Kishida, S.,
and Kikuchi, A.
(1999)
EMBO J.
18,
3629-3642[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Morinaka, K.,
Koyama, S.,
Nakashima, S.,
Hinoi, T.,
Okawa, K.,
Iwamatsu, A.,
and Kikuchi, A.
(1999)
Oncogene
18,
5915-5922[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Itoh, T.,
Koshiba, S.,
Kigawa, T.,
Kikuchi, A.,
Yokoyama, S.,
and Takenawa, T.
(2001)
Science
291,
1047-1051[Abstract/Free Full Text]
|
| 21.
|
Chen, H.,
Fre, S.,
Slepnev, V. I.,
Capua, M. R.,
Takei, K.,
Butler, M. H., Di,
Fiore, P. P.,
and De Camilli, P.
(1998)
Nature
394,
793-797[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Wendland, B.,
Steece, K. E.,
and Emr, S. D.
(1999)
EMBO J.
18,
4348-4393[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Drake, M. T.,
Downs, M. A.,
and Traub, L. M.
(2000)
J. Biol. Chem.
275,
6479-6489[Abstract/Free Full Text]
|
| 24.
|
Tsuchiya, M.,
Price, S. R.,
Tsai, S. C.,
Moss, J.,
and Vaughan, M.
(1991)
J. Biol. Chem.
266,
2772-2777[Abstract/Free Full Text]
|
| 25.
|
Boman, A. L.,
and Kahn, R. A.
(1995)
Trends Biochem. Sci.
20,
147-150[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Taylor, T. C.,
Kahn, R. A.,
and Melancon, P.
(1992)
Cell
70,
69-79[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Franco, M.,
Peters, P. J.,
Boretto, J.,
van Donselaar, E.,
Neri, A.,
D'Souza-Schorey, C.,
and Chavrier, P.
(1999)
EMBO J.
18,
1480-1491[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Song, J.,
Khachikian, Z.,
Radhakrishna, H.,
and Donaldson, J. G.
(1998)
J. Cell Sci.
111,
2257-2267[Abstract]
|
| 29.
|
Turner, C. E.
(2000)
Nat. Cell Biol.
2,
E231-E236[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Turner, C. E.,
West, K. A.,
and Brown, M. C.
(2001)
Curr. Opin. Cell Biol.
13,
593-599[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Kondo, A.,
Hashimoto, S.,
Yano, H.,
Nagayama, K.,
Mazaki, Y.,
and Sabe, H.
(2000)
Mol. Biol. Cell
11,
1315-1327[Abstract/Free Full Text]
|
| 32.
|
Okazaki, M.,
Kishida, S.,
Murai, H.,
Hinoi, T.,
and Kikuchi, A.
(1996)
Cancer Res.
56,
2387-2392[Abstract/Free Full Text]
|
| 33.
|
Matsubara, K.,
Hinoi, T.,
Koyama, S.,
and Kikuchi, A.
(1997)
FEBS Lett.
410,
169-174[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Okazaki, M.,
Kishida, S.,
Hinoi, T.,
Hasegawa, T.,
Tamada, M.,
Kataoka, T.,
and Kikuchi, A.
(1997)
Oncogene
14,
515-521[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Kariya, K.,
Koyama, S.,
Nakashima, S.,
Oshiro, T.,
Morinaka, K.,
and Kikuchi, A.
(2000)
J. Biol. Chem.
275,
18399-18406[Abstract/Free Full Text]
|
| 36.
|
Mazaki, Y.,
Hashimoto, S.,
Okawa, K.,
Tsubouchi, A.,
Nakamura, K.,
Yagi, R.,
Yano, H.,
Kondo, A.,
Iwamatsu, A.,
Mizoguchi, A.,
and Sabe, H.
(2001)
Mol. Biol. Cell
12,
645-662[Abstract/Free Full Text]
|
| 37.
|
Suzuki, J.,
Yamazaki, Y., Li, G.,
Kaziro, Y.,
and Koide, H.
(2000)
Mol. Cell. Biol.
20,
4658-4665[Abstract/Free Full Text]
|
| 38.
|
Klemke, R. L.,
Leng, J.,
Molander, R.,
Brooks, P. C.,
Vuori, K.,
and Cheresh, D. A.
(1998)
J. Cell Biol.
140,
961-972[Abstract/Free Full Text]
|
| 39.
|
Brown, M. T.,
Andrade, J.,
Radhakrishna, H.,
Donaldson, J. G.,
Cooper, J. A.,
and Randazzo, P. A.
(1998)
Mol. Cell. Biol.
18,
7038-7051[Abstract/Free Full Text]
|
| 40.
|
Holt, M. R.,
and Koffer, A.
(2001)
Trends Cell Biol.
11,
38-46[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Andreev, J.,
Simon, J. P.,
Sabatini, D. D.,
Kam, J.,
Plowman, G.,
Randazzo, P. A.,
and Schlessinger, J.
(1999)
Mol. Cell. Biol.
19,
2338-2350[Abstract/Free Full Text]
|
| 42.
|
Norman, J.,
Jones, D.,
Barry, S.,
Holt, M.,
Cockcroft, S.,
and Critchley, D.
(1998)
J. Cell Biol.
143,
1981-1995[Abstract/Free Full Text]
|
| 43.
|
Springer, S.,
Spang, A.,
and Schekman, R.
(1999)
Cell
97,
145-148[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Roth, M. G.
(1999)
Cell
97,
149-152[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Bretscher, M. S.
(1996)
Cell
87,
601-606[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Hopkins, C. R.,
Gibson, A.,
Shipman, M.,
Strickland, D. K.,
and Trowbridge, I. S.
(1994)
J. Cell Biol.
125,
1265-1274[Abstract/Free Full Text]
|
| 47.
|
Bretscher, M. S.,
and Aguado-Velasco, C.
(1998)
Curr. Biol.
8,
721-724[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
D'Souza-Schorey, C., Li, G.,
Colombo, M. I.,
and Stahl, P. D.
(1995)
Science
267,
1175-1178[Abstract/Free Full Text]
|
| 49.
|
Peters, P. J.,
Hsu, V. W.,
Ooi, C. E.,
Finazzi, D.,
Teal, S. B.,
Oorschot, V.,
Donaldson, J. G.,
and Klausner, R. D.
(1995)
J. Cell Biol.
128,
1003-1017[Abstract/Free Full Text]
|
| 50.
|
Radhakrishna, H., Al-,
Awar, O.,
Khachikian, Z.,
and Donaldson, J. G.
(1999)
J. Cell Sci.
112,
855-866[Abstract]
|
| 51.
|
Moskalenko, S.,
Henry, D. O.,
Rosse, C.,
Mirey, G.,
Camonis, J. H.,
and White, M. A.
(2002)
Nat. Cell Biol.
4,
66-72[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Sugihara, K.,
Asano, S.,
Tanaka, K.,
Iwamatsu, A.,
Okawa, K.,
and Ohta, Y.
(2002)
Nat. Cell Biol.
4,
73-78[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.